查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
临床前 CRO 市场——按服务（生物分析和 DMPK 试验、毒理学试验）、按最终用户（生物製药公司、政府和学术机构、医疗器械公司）、按地区和全球预测，2023-2032 年
市场调查报告书
商品编码
1262674

临床前 CRO 市场——按服务（生物分析和 DMPK 试验、毒理学试验）、按最终用户（生物製药公司、政府和学术机构、医疗器械公司）、按地区和全球预测，2023-2032 年

Preclinical CRO Market - By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By End-use (Biopharmaceutical Companies, Government & Academic Institutes, Medical Device Companies), By Region & Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 104 Pages | 商品交期: 2-3个工作天内

价格

临床前 CRO 市场将在 2032 年稳步增长，因为慢性病的增加和对有效治疗的需求不断增加预计会推动临床前研究中药物使用的增加。

此外，生物技术和製药公司通常选择外包来满足他们在临床前试验中的医疗需求，从而加快整个过程。 为此，进入临床前阶段的药物数量显着增加。

总体而言，临床前 CRO 市场在最终用途、服务和地域方面存在分歧。

在服务领域，“其他”子领域预计在估计期内将保持超过 7% 的复合年增长率的稳定增长率。 临床前CRO市场的其他服务包括生物利用度研究、生物等效性研究、药物相互作用研究服务等。

临床前 CRO 市场根据最终用途细分为政府/学术机构、生物製药公司、医疗设备公司等。 其中，政府和学术机构部门将在 2022 年占据超过 14.5% 的市场份额。 这种增长主要归因于委託给学术机构的研究和调查活动数量的增加。 学术机构和政府也正在提供临床前诊断和治疗的途径，这将推动未来临床前 CRO 行业的发展。

按地区划分，临床前 CRO 市场大致分为北美、欧洲、亚洲格局、市场格局和亚太地区。 其中，亚太地区临床前CRO市场有望在预测期内实现稳定增长。 该地区老年人口的增加，糖尿病、癌症、心脏病等慢性病患病率的增加，预计将补充市场增长。

此外，亚太地区肿瘤领域的研究药物和正在进行的临床前试验的数量正在增加，这有望推动该地区临床前 CRO 业务的规模。

另一方面，拉美地区的临床前 CRO 市场预计在分析期内也将出现强劲增长。 该地区拥有发达的医疗保健基础设施和成熟的监管环境。 这些因素使拉丁美洲成为临床前研究的沃土。

在临床前 CRO 市场运营的领先公司包括：Laboratory Corporation of America Inc.、Charles River Laboratory Inc.、Pharmaceutical Product Development. (PPD) LLC、ICON plc、Eurofins Scientific、Parexel International Corporation, Medpace, WuXi AppTec, SGS SA, Altasciences Company, Inc.

目录

第一章研究方法论

  • 调查方法
  • 市场范围和定义
  • 基本估算
  • 预测计算
  • 关于 COVID-19 的全球影响
  • 数据验证
  • 数据源
    • 二手数据
      • 付费资源
      • 无偿来源
    • 主要数据

第 2 章执行摘要

第 3 章临床前 CRO 行业洞察

  • 按行业细分
  • 行业格局，2018-2032 年版
  • 影响行业的因素
    • 司机
      • 全球研发支出增加
      • 扩大研发活动的外包
      • 临床前研究中的药物数量增加
    • 行业潜在的风险和挑战
      • 严格的监管政策
  • 增长分析
    • 按服务
    • 按最终用途
  • COVID-19 影响分析
  • 临床前研究的体积分析
    • 2018-2021 年按地区划分的临床前研究量分析
    • 临床前研究量分析，按适应症分类，2018-2021 年
    • 临床前研究量分析，按发展阶段，2018-2021 年
  • 监管状况
    • 美国
    • 欧洲
    • 亚太地区
      • 新加坡
      • 马来西亚
      • 印度尼西亚
      • 泰国
      • 韩国
      • 菲律宾
  • 临床试验 - 亚太优势
  • 价格/情况
  • 工业生态系统分析
  • 药物发现和开发过程
  • 波特分析
  • PESTEL 分析

第 4 章竞争格局，2022 年

  • 介绍
  • 公司矩阵分析，2022 年
  • 公司股票分析，2022 年
  • 战略仪錶盘，2022 年
  • 併购情况
    • CRO 行业的併购交易，2018-2022 年版
    • 完成合同研究所併购项目（2018-2021 年）
    • 私募股权对 CRO 併购的影响
      • PRA 健康科学
      • Medpace, Inc.
      • PPD
      • Parexel 国际公司
    • 行业重组对整体市场的影响
    • 分析师观点

第 5 章临床前 CRO 市场：按服务分类

  • 主要细分趋势
  • 生物分析和 DMPK 研究
  • 毒理学测试
  • 其他

第 6 章临床前 CRO 市场：按最终用途分类

  • 主要细分趋势
  • 生物製药公司
  • 政府机构、学术机构
  • 医疗设备製造商
  • 其他

第 7 章临床前 CRO 设备市场：按地区

  • 主要区域趋势
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 多边环境协定
    • 南非
    • 沙特阿拉伯

第八章公司简介

  • Charles River Laboratory, Inc.
  • Laboratory Corporation of America, Inc.
  • Pharmaceutical Product Development（PPD）, LLC（a part of Thermo Fisher Scientific）,
  • ICON plc
  • Eurofins Scientific
  • Parexel International Corporation
  • Medpace, Inc.
  • WuXi AppTec
  • SGS SA
  • Altasciences Company, Inc.
Product Code: 2860

Preclinical CRO Market is slated to grow at a robust rate through 2032 owing to the increasing usage of drugs during preclinical trials given the rising cases of chronic diseases and an increasing demand for effective treatment for the same. Besides, various biotechnology and pharmaceutical companies, quite often, opt for outsourcing to attain the medical needs for preclinical validations to fasten up the whole process. This has significantly propelled the number of drugs entering the preclinical phase.

Overall, the preclinical CRO market has been bifurcated in terms of end-use, service, and region.

Within the service segment, the others subsegment is slated to grow at a steady rate of more than 7% CAGR through the estimated timeframe. The other services in the preclinical CRO market comprise bioavailability testing, bioequivalence testing, drug-interaction testing services, etc.

Based on end-use, the preclinical CRO market has been divided into government & academic institutes, biopharmaceutical companies, medical device companies, and others. Among them, the government & academic institutes segment held more than 14.5% market share in 2022. The growth can be primarily attributed to the increasing number of research and R&D activities that are outsourced to academic institutes. Besides, academic institutes and the governments are also providing diagnosis and access to treatments under preclinical trials, which is likely to propel the preclinical CRO industry growth in the upcoming time.

In the regional landscape, the preclinical CRO market has been broadly categorized into North America, Europe, LATAM, MEA, and Asia Pacific. Among them, the preclinical CRO market in the Asia Pacific region is anticipated to grow at a steady rate over the estimated timeframe. The increasing geriatric population in this region and rising cases of chronic diseases like diabetes, cancer, and cardiac diseases are anticipated to supplement the market growth.

Additionally, an increase in the number of investigational compounds and ongoing preclinical trials in oncology in Asia Pacific will boost the preclinical CRO business size in this region.

Meanwhile, the preclinical CRO market in the LATAM region is also slated to grow at a robust rate through the analysis timeframe. The healthcare infrastructure in this region is well-developed and it also boasts a well-established regulatory environment. These factors enable Latin America to be a fertile landscape to allow preclinical research to be conducted easily.

Some of the key companies operating in the preclinical CRO market are: Laboratory Corporation of America Inc., Charles River Laboratory Inc., Pharmaceutical Product Development (PPD) LLC, ICON plc, Eurofins Scientific, Parexel International Corporation, Medpace, Inc., WuXi AppTec, SGS SA, Altasciences Company, Inc.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market scope and definition
  • 1.3 Base estimates
  • 1.4 Forecast calculations
  • 1.5 COVID-19 impact at global level
  • 1.6 Data validation
  • 1.7 Data Sources
    • 1.7.1 Secondary
      • 1.7.1.1 Paid sources
      • 1.7.1.2 Unpaid sources
    • 1.7.2 Primary

Chapter 2 Executive Summary

  • 2.1 Preclinical CRO industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Service trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 Preclinical CRO Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing R&D expenditure worldwide
      • 3.3.1.2 Growing outsourcing of R&D activities
      • 3.3.1.3 Rising number of drugs in preclinical trails
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Stringent regulatory policies
  • 3.4 Growth potential analysis
    • 3.4.1 By service
    • 3.4.2 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Preclinical trial volume analysis
    • 3.6.1 preclinical trial volume analysis, by region, 2018 - 2021
    • 3.6.2 preclinical trial volume analysis, by indication, 2018 - 2021
    • 3.6.3 preclinical trial volume analysis, by phase of development, 2018 - 2021
  • 3.7 Regulatory landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
    • 3.7.3 Asia Pacific
      • 3.7.3.1 Singapore
      • 3.7.3.2 Malaysia
      • 3.7.3.3 Indonesia
      • 3.7.3.4 Thailand
      • 3.7.3.5 South Korea
      • 3.7.3.6 Philippines
  • 3.8 Clinical trials- Asia Pacific advantage
  • 3.9 Pricing Landscape
  • 3.10 Industry ecosystem analysis
  • 3.11 Drug discovery and development process
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company market share analysis, 2022
  • 4.4 Strategic dashboard, 2022
  • 4.5 Merger & acquisition landscape
    • 4.5.1 Merger & acquisition deals in the CRO industry, 2018 - 2022
    • 4.5.2 Completed contract research organization merger & acquisition deals, 2018-2021
    • 4.5.3 Influence of private equity in CRO mergers & acquisitions
      • 4.5.3.1 PRA Health Sciences
      • 4.5.3.2 Medpace, Inc.
      • 4.5.3.3 PPD, Inc.
      • 4.5.3.4 Parexel International Corporation
    • 4.5.4 Impact of industry consolidation on the overall market
    • 4.5.5 Analyst insights

Chapter 5 Preclinical CRO Market, By Service

  • 5.1 Key segment trends
  • 5.2 Bioanalysis & DMPK studies
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Toxicology testing
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Others
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Preclinical CRO Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Biopharmaceutical companies
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Government and academic institutes
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Medical devices companies
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 Others
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Preclinical CRO Devices Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia

Chapter 8 Company Profiles

  • 8.1 Charles River Laboratory, Inc.
  • 8.2 Laboratory Corporation of America, Inc.
  • 8.3 Pharmaceutical Product Development (PPD), LLC (a part of Thermo Fisher Scientific),
  • 8.4 ICON plc
  • 8.5 Eurofins Scientific
  • 8.6 Parexel International Corporation
  • 8.7 Medpace, Inc.
  • 8.8 WuXi AppTec
  • 8.9 SGS SA
  • 8.10 Altasciences Company, Inc.

Data Tables

  • TABLE 1. Global preclinical CRO market, 2018 - 2022 (USD Million)
  • TABLE 2. Global preclinical CRO market, 2023 - 2032 (USD Million)
  • TABLE 3. Global preclinical CRO market, by service, 2018 - 2022 (USD Million)
  • TABLE 4. Global preclinical CRO market, by service, 2023 - 2032 (USD Million)
  • TABLE 5. Global preclinical CRO market, by end-use, 2018 - 2022 (USD Million)
  • TABLE 6. Global preclinical CRO market, by end-use, 2023 - 2032 (USD Million)
  • TABLE 7. Global preclinical CRO market, by region, 2018 - 2022 (USD Million)
  • TABLE 8. Global preclinical CRO market, by region, 2023 - 2032 (USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Mergers and acquisitions landscape, 2018 - 2022
  • TABLE 11. Bioanalysis & DMPK studies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 12. Bioanalysis & DMPK studies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 13. Toxicology testing market size, by region, 2018 - 2022 (USD Million)
  • TABLE 14. Toxicology testing market size, by region, 2023 - 2032 (USD Million)
  • TABLE 15. Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 16. Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 17. Biopharmaceutical companies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 18. Biopharmaceutical companies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 19. Government & academic institutes market size, by region, 2018 - 2022 (USD Million)
  • TABLE 20. Government & academic institutes market size, by region, 2023 - 2032 (USD Million)
  • TABLE 21. Medical device companies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 22. Medical device companies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 23. Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 24. Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 25. North America preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 26. North America preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 27. North America preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 28. North America preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 29. North America preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 30. North America preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 31. U.S. preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 32. U.S. preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 33. U.S. preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 34. U.S. preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 35. Canada preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 36. Canada preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 37. Canada preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 38. Canada preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 39. Europe preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 40. Europe preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 41. Europe preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 42. Europe preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 43. Europe preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 44. Europe preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 45. Germany preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 46. Germany preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 47. Germany preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 48. Germany preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 49. UK preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 50. UK preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 51. UK preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 52. UK preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 53. France preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 54. France preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 55. France preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 56. France preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 57. Italy preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 58. Italy preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 59. Italy preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 60. Italy preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 61. Spain preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 62. Spain preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 63. Spain preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 64. Spain preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 65. Asia Pacific preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 66. Asia Pacific preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 67. Asia Pacific preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 68. Asia Pacific preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 69. Asia Pacific preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 70. Asia Pacific preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 71. Japan preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 72. Japan preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 73. Japan preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 74. Japan preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 75. China preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 76. China preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 77. China preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 78. China preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 79. India preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 80. India preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 81. India preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 82. India preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 83. Australia preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 84. Australia preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 85. Australia preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 86. Australia preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 87. Latin America preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 88. Latin America preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 89. Latin America preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 90. Latin America preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 91. Latin America preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 92. Latin America preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 93. Brazil preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 94. Brazil preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 95. Brazil preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 96. Brazil preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 97. Mexico preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 98. Mexico preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 99. Mexico preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 100. Mexico preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 101. MEA preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 102. MEA preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 103. MEA preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 104. MEA preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 105. MEA preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 106. MEA preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 107. South Africa preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 108. South Africa preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 109. South Africa preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 110. South Africa preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 111. Saudi Arabia preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 112. Saudi Arabia preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 113. Saudi Arabia preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 114. Saudi Arabia preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1. Top-down approach
  • FIG 2. Breakdown of primary participants
  • FIG 3. Preclinical industry 360 degree synopsis, 2018 - 2032
  • FIG 4. Industry segmentation
  • FIG 5. Industry landscape, 2018-2032 (USD Million)
  • FIG 6. Growth potential analysis, by service
  • FIG 7. Growth potential analysis, by end-use
  • FIG 8. Industry ecosystem analysis
  • FIG 9. Drug discovery and development process
  • FIG 10. Company matrix analysis, 2022
  • FIG 11. Strategy dashboard, 2022
  • FIG 12. Key segment trends, by service
  • FIG 13. Key segment trends, by end-use
  • FIG 14. Key regional trends